Underlying EBITDA as per updated guidance in May, so nothing to...

Underlying EBITDA as per updated guidance in May, so nothing to see there...

FY19 Outlook seems to be better considering the reduction in operating costs as per planned with a bit more than one third achieved already. Trading outlook as per below seems good too..standalone GP clinics LFL fall in sales seem to have decelerated..

Trading update as at week 6:
• 5.8% Group LFL sales growth
• 6.1% Group Retail LFL sales growth
• 5.2% Australian Vet LFL sales growth including negative LFL sales in standalone GP clinics of 0.5%
• 8.0% Group revenue growth